ArticleIndian journal of surgical oncology2026
How to Treat and Reconstruct the Pelvis After Chondrosarcoma Resection: Indications and Results at Medium- and Long-term in a Series of 34 patients.
Article in Indian journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pelvic chondrosarcomas (CS) present complex diagnostic and therapeutic challenges due to their insidious onset and deep anatomical location. This study analyzes clinical, surgical, oncological, and functional outcomes in a consecutive series of 34 patients treated with wide resection, with the aim of proposing a surgical decision-making flowchart based on tumor localization. All patients with pelvic CS treated with wide resection between February 2005 and December 2021 were retrospectively reviewed. Epidemiological data, imaging, surgical details, histology, complications, oncologic outcomes, and functional results were collected. Tumor localization followed the Enneking and Dunham classification. Preoperative biopsy underestimated tumor grade in over 50% of cases. Wound infection was the most common complication (64.7%) and leading cause of perioperative mortality. Surgical Duration correlated with complication risk. Five-year overall survival was 60.2%, significantly influenced by age and histological grade. Local recurrence occurred in 10.3% of cases, associated with higher-grade tumors. Functional outcomes varied by resection site, with better scores in type I and III resections. Reconstruction strategies were adapted to anatomical site, tumor extension, and patient condition. Histological grade and age are key prognostic factors in pelvic CS. Wide resection remains essential due to frequent underestimation of tumor aggressiveness. Surgical approach and reconstruction should be tailored to tumor location to optimize oncologic control and functional outcome. A flowchart is proposed to guide surgical planning. Larger, more specific series are recommended to attain statistical significance and validate our findings and protocol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.